| __timestamp | Bio-Techne Corporation | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 2242216 |
| Thursday, January 1, 2015 | 40853000 | 4536244 |
| Friday, January 1, 2016 | 45187000 | 5184803 |
| Sunday, January 1, 2017 | 53514000 | 3068742 |
| Monday, January 1, 2018 | 55329000 | 7178000 |
| Tuesday, January 1, 2019 | 62413000 | 16267000 |
| Wednesday, January 1, 2020 | 65192000 | 23191000 |
| Friday, January 1, 2021 | 70603000 | 21453000 |
| Saturday, January 1, 2022 | 87140000 | 15265000 |
| Sunday, January 1, 2023 | 92493000 | 25189000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing insights
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bio-Techne Corporation and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. Bio-Techne has consistently increased its R&D budget, with a notable 212% rise from 2014 to 2023. This upward trend underscores their commitment to innovation and market leadership. In contrast, Soleno Therapeutics, while showing a significant increase of over 1,000% from 2014 to 2023, experienced more volatility, reflecting the challenges faced by smaller biotech firms. Notably, Soleno's R&D expenses peaked in 2023, highlighting a strategic push towards new developments. However, data for 2024 is missing, leaving room for speculation on future trends. This analysis provides a window into the strategic priorities of these companies, offering valuable insights for investors and industry stakeholders.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
United Therapeutics Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Apellis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Soleno Therapeutics, Inc. vs Travere Therapeutics, Inc.
Comparing Innovation Spending: Soleno Therapeutics, Inc. and Evotec SE